Altimmune, Inc. (ALT)

3.475 -0.04 (-1.28%) USD  |  NASDAQ  |  Apr 17, 13:51
More

Altimmune Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade